Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3

Antiviral Research

Volumn 72, Issue 1, 2006, Pages 1-9

  Tanaka, Yoshikazu ^d   Kato, Junko ^a   Kohara, Michinori ^b   Galinski, Mark S ^c  

^a Tokyo Women s Medical University   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c MERCK RESEARCH LABORATORIES   (United States)

^d NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Glycosylation inhibitors; Human parainfluenza virus type 3; Oligosaccharide processing

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; 1 DEOXYNOJIRIMYCIN; ALPHA GLUCOSIDASE INHIBITOR; ALPHA MANNOSIDASE; BROMOCONDURITOL; CASTANOSPERMINE; MANNOSIDASE INHIBITOR; OLIGOSACCHARIDE; SWAINSONINE; VIRUS GLYCOPROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL SURFACE; DRUG MECHANISM; ENDOPLASMIC RETICULUM; GENE EXPRESSION SYSTEM; GENETIC RECOMBINATION; GLYCOSYLATION; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; VIRUS INFECTIVITY;

ALPHA-GLUCOSIDASES; ALPHA-MANNOSIDASE; ANIMALS; CELL LINE; ENZYME INHIBITORS; GLUCOSE; GLYCOSYLATION; HN PROTEIN; HUMANS; PARAINFLUENZA VIRUS 3, HUMAN; RECOMBINANT PROTEINS; TRANSFECTION; VIRAL FUSION PROTEINS; VIRUS REPLICATION;

HUMAN PARAINFLUENZA VIRUS 3;

EID: 33747892601     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.03.016     Document Type: Article

References (26)

1. Alper J. Saving lives with sugar. Science 291 5512 (2001) 2339
2. Alper J. Searching for medicine's sweet spot. Science 291 5512 (2001) 2338-2343
3. Bolt G. The measles virus (MV) glycoproteins interact with cellular chaperones in the endoplasmic reticulum and MV infection upregulates chaperone expression. Arch. Virol. 146 11 (2001) 2055-2068
4. Branza-Nichita N., Durantel D., Carrouee-Durantel S., Dwek R.A., and Zitzmann N. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers. J. Virol. 75 8 (2001) 3527-3536
5. Cote M.J., Storey D.G., Kang C.Y., and Dimock K. Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus type 3 fusion glycoprotein gene. J. Gen. Virol. 68 Pt. 4 (1987) 1003-1010
6. Courageot M.P., Frenkiel M.P., Dos Santos C.D., Deubel V., and Despres P. Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J. Virol. 74 1 (2000) 564-572
7. Dwek R.A., Butters T.D., Platt F.M., and Zitzmann N. Targeting glycosylation as a therapeutic approach. Nat. Rev. Drug Discov. 1 1 (2002) 65-75
8. Ebata S.N., Cote M.J., Kang C.Y., and Dimock K. The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology 183 1 (1991) 437-441
9. Hammond C., Braakman I., and Helenius A. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc. Natl. Acad. Sci. USA 91 3 (1994) 913-917
10. Heminway B.R., Yu Y., and Galinski M.S. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res. 31 1 (1994) 1-16
11. Mehta A., Zitzmann N., Rudd P.M., Block T.M., and Dwek R.A. Alpha-glucosidase inhibitors as potential broad based anti-viral agents. FEBS Lett. 430 1-2 (1998) 17-22
12. Molinari M., and Helenius A. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288 5464 (2000) 331-333
13. Nakhasi H.L., Ramanujam M., Atreya C.D., Hobman T.C., Lee N., Esmaili A., and Duncan R.C. Rubella virus glycoprotein interaction with the endoplasmic reticulum calreticulin and calnexin. Arch. Virol. 146 1 (2001) 1-14
14. Papandreou M.J., Barbouche R., Guieu R., Kieny M.P., and Fenouillet E. The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step. Mol. Pharmacol. 61 1 (2002) 186-193
15. Peterson J.R., Ora A., Van P.N., and Helenius A. Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins. Mol. Biol. Cell 6 9 (1995) 1173-1184
16. Saito T., and Yamaguchi I. Effect of glycosylation and glucose trimming inhibitors on the influenza A virus glycoproteins. J. Vet. Med. Sci. 62 6 (2000) 575-581
17. Spriggs M.K., and Collins P.L. Intracellular processing and transport of NH2-terminally truncated forms of a hemagglutinin-neuraminidase type II glycoprotein. J. Cell Biol. 111 1 (1990) 31-44
18. Storey D.G., Cote M.J., Dimock K., and Kang C.Y. Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus 3 hemagglutinin-neuraminidase gene: comparison with other paramyxoviruses. Intervirology 27 2 (1987) 69-80
19. Tanaka Y., and Galinski M.S. Human parainfluenza virus type 3: analysis of the cytoplasmic tail and transmembrane anchor of the hemagglutinin-neuraminidase protein in promoting cell fusion. Virus Res. 36 2-3 (1995) 131-149
20. Tanaka Y., Heminway B.R., and Galinski M.S. Down-regulation of paramyxovirus hemagglutinin-neuraminidase glycoprotein surface expression by a mutant fusion protein containing a retention signal for the endoplasmic reticulum. J. Virol. 70 8 (1996) 5005-5015
21. Tomita Y., Yamashita T., Sato H., and Taira H. Kinetics of interactions of sendai virus envelope glycoproteins, F and HN, with endoplasmic reticulum-resident molecular chaperones, BiP, calnexin, and calreticulin. J. Biochem. (Tokyo) 126 6 (1999) 1090-1100
22. Wojczyk B., Shakin-Eshleman S.H., Doms R.W., Xiang Z.Q., Ertl H.C., Wunner W.H., and Spitalnik S.L. Stable secretion of a soluble, oligomeric form of rabies virus glycoprotein: influence of N-glycan processing on secretion. Biochemistry 34 8 (1995) 2599-2609
23. Wu S.F., Chang J.S., Wan L., Tsai C.H., and Tsai F.J. Association of IL-1Ra gene polymorphism, but no association of IL-1beta and IL-4 gene polymorphisms, with Kawasaki disease. J. Clin. Lab. Anal. 19 3 (2005) 99-102
24. Wu S.F., Lee C.J., Liao C.L., Dwek R.A., Zitzmann N., and Lin Y.L. Antiviral effects of an iminosugar derivative on flavivirus infections. J. Virol. 76 8 (2002) 3596-3604
25. Zhang J.X., Braakman I., Matlack K.E., and Helenius A. Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. Mol. Biol. Cell 8 10 (1997) 1943-1954
26. Zitzmann N., Mehta A.S., Carrouee S., Butters T.D., Platt F.M., McCauley J., Blumberg B.S., Dwek R.A., and Block T.M. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc. Natl. Acad. Sci. USA 96 21 (1999) 11878-11882